| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |